Imatinib (as Mesylate) Capsule
Imatinib (as Mesylate) is a compounded formulation containing imatinib (as mesylate), prepared by Mixlab for veterinary use. Available by prescription.
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Imatinib mesylate is a tyrosine kinase inhibitor utilized in veterinary medicine for its antineoplastic properties. It is a prescription medication available for use in dogs and cats, requiring professional guidance and monitoring by a licensed veterinarian. It is frequently considered in the context of oncology for patients presented with mast cell tumors or specific types of leukemia.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it manages the signaling pathways involved in cell growth by blocking specific tyrosine kinase enzymes. Commonly observed effects include localized digestive changes such as vomiting or diarrhea and behavioral shifts like lethargy. A significant clinical consideration is the potential for bone marrow suppression or renal changes; your veterinarian will perform regular blood tests to monitor these physiological markers. Owners should monitor for pale gums or unusual bruising and contact their veterinarian promptly with any concerns.
Yes. Imatinib is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all professional requirements before preparing any medication.
Yes. Mixlab specializes in compounding imatinib into customized strengths and flavored oral formats, such as flavored oral liquids or capsules, to suit the specific needs of your pet. The decision rests with your prescribing veterinarian.
Veterinarians discuss imatinib because it inhibits the signals that tell certain cancer cells to divide and grow. This provides a method for managing the progression of specific oncological challenges.
Because imatinib influences cell production, your veterinarian will recommend wearing gloves when handling the medication. This provides a method for preventing accidental absorption during administration.
Your veterinarian will recommend frequent blood work, including a complete blood count (CBC) and liver enzymes. This monitoring ensures the management approach remains safe for your pet's health status.
